Home > News > Triton's nanotechnology designed to take on tumors
May 1st, 2004
Triton's nanotechnology designed to take on tumors
Samuel Straface is betting that nanotechnology originally designed to repair military vehicles can be successfully used for something far different: to kill cancer tumors. Straface is president and CEO of Triton BioSystems Inc. in Chelmsford, a 3-year-old biotechnology/medical device company hybrid. And he believes the company's system will essentially fry a tumor without significant side effects, ultimately helping to treat patients in lieu of toxic chemotherapy or radiation.
Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014
Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014
ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014
An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014